The Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Science Research Council (EPSRC) and Medical Research Council (MRC) are establishing a £25M UK Regenerative Medicine Platform (UKRMP) to address the technical and scientific challenges associated with translating promising scientific discoveries in this area towards clinical impact.
As part of the first stage in the establishment of the UKRMP, three interdisciplinary and complementary research Hubs have been established which together provide a world-leading programme to promote the development of regenerative therapies.
- Stem cell niche Hub – engineering and exploiting the niche
- Safety and efficacy Hub – focussing on imaging technologies
- Acellular (smart material) approaches for therapeutic delivery Hub
Each of the Hubs provides a UK centre of expertise/knowledge with the necessary critical mass to address key translational challenges and provide new tools, protocols and resources with broad applicability that can be utilised by other UK research groups in academia and industry.
The Hubs provide a cornerstone of the broader UK research strategy in this area, which is seeking to support high quality UK research activity and translational activity that will help deliver the great promise of regenerative medicine to the benefit of both patients and future economic growth.
Friday, May 3, 2013
The Medical Research Council (MRC) is announcing an investment of £20M for capital only funding which will support research addressing [...]More »
Friday, April 5, 2013
The Medical Research Council (MRC) and British Heart Foundation (BHF) today announced £20m of funding to boost the development of [...]More »
Wednesday, March 13, 2013
The Medical Research Council (MRC) have launched a call for Expressions of Interest to support regenerative medicine research. The purpose [...]More »